






Секция 1: Актуальные проблемы физики 
 14
USE OF SILVER NANOPARTICLES IN TREATMENT OF SOCIALLY SIGNIFICANT DISEASES 
M.G. Grigoriev, PhD student, L.N. Babich, student, 
National Research Tomsk Polytechnic University, Tomsk  
634050, Tomsk, Lenin Avenue, 30, phone. +7(913) 824-83-97 
E-mail: Mishatpu@mail.ru 
Provision of high efficacy and quality of drugs developed based on nanotechnology is possible only 
in case of compliance with the requirements for the development, study, introduction and production of new 
pharmaceuticals. While determining the toxicological characteristics of substances, determination of geno-
toxicity and cytotoxicity is the first stage, the purpose of which is to determine the ability to induce primary 
DNA damage, as well as the possible negative effects on cell cultures. Taking into account the need for the 
introduction of new antimicrobial agents it is reasonable to develop combined agents that would have better 
efficacy and safety indicators. The studies of nanosilver-based drugs acting against antibiotic-resistant mi-
croorganisms, cytotoxicity and genotoxicity study of nanocomposite, finely dispersed silica and silver nano-
particles produced by alkaline single cell-gel electrophoresis assay are of significant scientific and practical 
interest. It has been demonstrated that finely dispersed silica nanocomposite with silver nanoparticles has no 
genotoxic properties, and its cytotoxicity disappears at concentrations below 0.007% [1 – 3].  
Creation of functional nanomaterials and nanodevices is the most promising using the nanoparticles 
obtained by the chemical solution methods. These methods allow producing nanoparticles, especially from 
precious metals such as gold and silver, with a profusive variety of composition, structure, shapes and sizes. 
Possible applications of nanoparticles are not limited to a certain range. They are widely used for di-
agnostics and treatment of various diseases, including cancer. They are also used in immunochemical stu-
dies. So, they have been extensively studied in a new sect of experimental medicine, which is now called 
“nanomedicine”. According to the literature it is known that, in particular, the silver nanoparticles may be 
used to produce a wide range of materials with antibacterial properties. At the same time, it has been found 
over the past few years that different nanoparticles when they enter the body, can lead to the development of 
serious diseases (nanopathologies). It is also emphasized that metal nanoparticles can enter the body in dif-
ferent ways, for example, through the mucous membranes of the respiratory tract and digestive system and 
through the skin when using cosmetics. They can penetrate through the bloodstream as an ingredient of vac-
cines and serums, etc. The risk of the spread of diseases of that type (nanopathologies) has been still not en-
tirely investigated or realized. However, their importance is great today and in it is obvious that it will in-
crease in the future. The determination of the causes of “harmful” (pathological) effect of nanoparticles and 
development of the ways to control the manifestations of diseases associated therewith are still going on. 
The question raised by the penetration of nanoparticles into the body remains an open one. Therefore, this 
area is now becoming the subject of the new and developing sect in the modern experimental medicine [4]. 
Thus it can be said without prejudice that determination of additional ways, as well as the methods of 
nanoparticle effect is continuously going on. This especially applies to the effect of metal nanoparticles on 
the living organism. It is still critically important and popular in researches and developments. The need is 
expressed in improvement of existing prototypes, as well as production of new generations of drugs. This 
will be followed by the development of the new treatment methods in the field of nanomedicine. These as-
pects will allow revealing the features to determine the causes of nanopathologies emergence. They will also 
allow determining and developing science-based and acceptable ranges of concentration and size of nano-
particles, depending on their location: in water, air or as a part of various materials, which a human contacts 
with. Further opportunities to study the properties of silver nanoparticles are being expanded. The develop-
ment of options of their practical application reaches higher heights. Determination of the mechanisms of 
their biological effect on the macroorganism is being improved. The method for the production thereof 
largely depends on them. The latter is a criterion determining in many cases their structure, sizes, physical 
and chemical properties. Finally everything lies in stability, which specifies the lifetime of certain nanosized 
particles. In recent years, among the variety of methods for production of nanoparticles the chemical synthe-
sis methods based on the reduction of metal ions to atoms form a large group. This can occur in solutions, 
and in other conditions that are favorable to the subsequent aggregation of the atoms and ions to form the 
necessary nanoparticles [5]. 
The modern arsenal of pharmacotherapy has a wide range of potent drugs. However, despite this, the 
results of treatment are often not very satisfactory. Among the many factors that reduce the efficacy of exist-
ing drugs, it should be noted that they have extremely unfavorable biodistribution. It may be due to the spe-
cific features and difficulties in their penetration into the nidus. The underlying causes of such a pattern may 
include hindered access to the target organ due to the structural features of specific tissues (presence of dif-
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and/or physico-chemical properties of the drug. The usual way to overcome this obstacle is to increase 
treatment efficacy by increasing its dose. The drawback of this method of achieving therapeutic effect is 
surely the increase in the non-specific toxicity of the drug used. In this regard, the specified problem is of 
utmost importance in cases of application of potent drugs. These include, for example, antineoplastic agents 
and antibiotics. Their application is always associated with various side effects. It is often a factor that vi-
tiates all efforts [6 – 8]. 
In view of the aforesaid polymeric nanoparticles are of particular interest. These are the particles 
from 10 to 1000 nm. Their dimension is a criterion determining stability and required capacity in respect to a 
broad spectrum of drugs [9]. 
It should be emphasized that this is a long-term use of high doses of silver (solution concentration 30 
- 50 mg/l) over many years for therapeutic purposes. It is also observed when using silver compounds under 
production conditions. This may lead to the deposition of silver in the skin and the subsequent change of 
skin color. This is called argyria, an occupational disease of jewelers when the skin is getting tanned. It re-
sults from the photochemical reduction of silver ions in the skin thickness. However, no changes in the func-
tional state of organs and systems have been revealed when examining such patients. No abnormal findings 
in the biochemical processes taking place in the body have been detected as well. Only increased resistance 
to most viral and bacterial infections was observed in all people with symptoms of argyria [10]. 
Over the last years there has been certain information in domestic and foreign scientific literature that 
silver is a potent immunomodulator. This action is comparable only with steroid hormones. It has been also 
found that silver can both stimulate and inhibit the phagocytosis depending on the dose used. It has been 
noted, that under the action of silver particles the amount of immunoglobulin of IgA, IgM-, IgG- classes is 
increased and the percentage of T-lymphocytes is increased as well [11]. 
Thus, the analysis of the contemporary literature is indicative of an urgent need to create fundamentally 
new drugs for the treatment of socially significant diseases on the basis of modern nanotechnology. Nanosilver-
based ointment for the treatment of infectious dermatitis, nanoiron capsules for the treatment of anemia, nanosized 
silica (silics) for the treatment of poisoning, lipoflamin for the treatment of myocardial infarction are already used 
in clinical practice today. However, there are no effective and safe drugs for the treatment of viral diseases, includ-
ing HIV, hepatitis, influenza, herpes, Alzheimer’s disease, Parkinson’s disease, malignant tumors, infectious dis-
eases, which are caused by antibiotic-resistant strains of microorganisms, endocrine system disorders (diabetes, 
myxedema) schizophrenia, epilepsy, manic-depressive illness. 
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